High habitual dietary alpha-linolenic acid intake is associated with decreased plasma soluble interleukin-6 receptor concentrations in male twins

Am J Clin Nutr. 2010 Jul;92(1):177-85. doi: 10.3945/ajcn.2010.29305. Epub 2010 May 12.

Abstract

Background: alpha-Linolenic acid (ALA) is associated with a low risk of cardiovascular disease; however, the underlying mechanism is not completely known.

Objective: The objective was to examine whether habitual dietary ALA intake is associated with plasma concentrations of inflammatory biomarkers after control for shared genetic and common environmental factors.

Design: We cross-sectionally studied 353 middle-aged male twins. Habitual diet was assessed with the Willett food-frequency questionnaire. Fasting plasma concentrations of interleukin-6 (IL-6) and its soluble receptor (sIL-6R), high-sensitivity C-reactive protein (hsCRP), and tumor necrosis factor-alpha (TNF-alpha) were measured. Linear mixed-effect regression analysis was used to partition the overall association into within- and between-pair associations.

Results: A 1-g increment in habitual dietary ALA intake was associated with 11.0% lower concentrations of sIL-6R (P = 0.004) but not of IL-6 (P = 0.31), TNF-alpha (P = 0.16), or hsCRP (P = 0.36) after adjustment for energy intake, nutritional factors, known cardiovascular disease risk factors, and medications. After further control for shared genetic and common environmental factors by comparison of brothers within a twin pair, a twin with a 1-g higher ALA intake was likely to have 10.9% (95% CI: 3.7%, 17.6%; P = 0.004) lower sIL-6R concentrations than his co-twin with a low intake, whereas ALA intake was not significantly associated with plasma concentrations of IL-6, TNF-alpha, or hsCRP. These results were validated by using 1000 bootstrap samples.

Conclusions: Habitual dietary ALA intake is inversely associated with plasma sIL-6R concentrations independent of shared genetic and common environmental influences. Lowering sIL-6R may be a mechanism underlying the cardioprotective properties of habitual dietary ALA. This study was registered at clinicaltrials.gov as NCT00017836.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Twin Study

MeSH terms

  • C-Reactive Protein / drug effects
  • C-Reactive Protein / metabolism
  • Cardiovascular Diseases / epidemiology
  • Cardiovascular Diseases / psychology
  • Depression / epidemiology
  • Diet*
  • Dietary Supplements
  • Energy Intake
  • Fatty Acids / metabolism
  • Humans
  • Interleukin-6 / blood
  • Life Style
  • Lipids / blood
  • Male
  • Middle Aged
  • Receptors, Interleukin-6 / blood*
  • Receptors, Interleukin-6 / drug effects
  • Risk Factors
  • Surveys and Questionnaires
  • Tumor Necrosis Factor-alpha / blood
  • Tumor Necrosis Factor-alpha / drug effects
  • Twins, Dizygotic
  • Twins, Monozygotic
  • Waist-Hip Ratio
  • alpha-Linolenic Acid / pharmacology*

Substances

  • Fatty Acids
  • Interleukin-6
  • Lipids
  • Receptors, Interleukin-6
  • Tumor Necrosis Factor-alpha
  • alpha-Linolenic Acid
  • C-Reactive Protein

Associated data

  • ClinicalTrials.gov/NCT00017836